VisiTech International | Live Cell Super Resolution Imaging
VisiTech International’s mission is to provide high quality innovative imaging instrumentation and associated peripherals to the Life Sciences and Materials Sciences communities. The success of VisiTech International has been achieved through an uncompromising approach to the analysis and design of equipment to meet market needs and the provision of comprehensive after sales support to our customer base. Since its inception VisiTech has secured many distribution channels throughout the world, as well as establishing relationships with leading manufacturers, such as Nikon Instruments, Hamamatsu Corp, Olympus, PI, CVI Melles Griot, Molecular Devices. VisiTech International is committed to substantial investment in Research & Development aimed at securing its position in existing markets and extending the scope of application of its technology to emerging fields. Finally, in 2018 VisiTech patented Ingwaz scanning architecture and applied this new technology to VT-iSIM. We are on the way to achieving our primary objective, which is to be recognised as a leading player in these markets with a particular emphasis on imaging of dynamic fluorescence. Our aim is to provide innovative super resolution and confocal imaging technology to the life and material science communities. With a combination of multi-point scanning and VisiTech’ patented Ingwaz scanning architecture, the system offers very low photo-bleaching and incredibly high signal to noise.
This company is:
Verified
A new experimental platform facilitatesassessment of the transcriptional and chromatin landscapes of aging yeast - VisiTech International
Authors: David G Hendrickson, Ilya Soifer, Bernd J Wranik, Griffin Kim, Michael Robles, Patrick A Gibney†, R Scott McIsaac* Replicative aging of Saccharomyces cerevisiae is an established model system for eukaryotic cellular aging. A limitation in yeast lifespan studies has been the difficulty of separating old cells from young cells in large quantities. We...
Verified
Interferon-γ signaling in human iPSC–derived neurons recapitulates neurodevelopmental disorder phenotypes - VisiTech International
Authors: Katherine Warre-Cornish, Leo Perfect, Roland Nagy, Rodrigo R. R. Duarte, Matthew J. Reid, Pooja Raval, Annett Mueller, Amanda L. Evans, Amalie Couch, Cédric Ghevaert, Grainne McAlonan, Eva Loth, Declan Murphy, Timothy R. Powell, Anthony C. Vernon, Deepak P. Srivastava, Jack Price Maternal immune activation increases the risk of neurodevelopmental disorders. Elevated cytokines, such as...
Verified
γδ T cells compose a developmentally regulated intrauterine population and protect against vaginal candidiasis - VisiTech International
Authors: L. Monin, D. S. Ushakov, H. Arnesen, N. Bah, A. Jandke, M. Muñoz-Ruiz, J. Carvalho, S. Joseph, B. C. Almeida, M. J. Green, E. Nye, S. Hatano, Y. Yoshikai, M. Curtis, H. Carlsen, U. Steinhoff, P. Boysen & A. Hayday This most comprehensive analysis to date of γδ T cells in the murine uterus...
View all products
Keywords
Industries
Applications - VisiTech International
Find out about the multiple applications of our innovative products
How many employees does VISITECH INTERNATIONAL LIMITED approximately have?
As of the latest available information VISITECH INTERNATIONAL LIMITED has around 1-10 employees worldwide.
In which industries does VISITECH INTERNATIONAL LIMITED mainly work?
The company VISITECH INTERNATIONAL LIMITED has it's main focus in the industries of Research
Visitech AS
Norway
11-50 Employees
2001
View
TT Vision Holdings
Malaysia
51-100 Employees
2001
View
Visics Corporation
United States
1-10 Employees
1994
View
Viztronics Smart Solutions
Ireland
1-10 Employees
2018
View
Tech4Imaging
United States
11-50 Employees
2007
View
Vision Tech Group
Belgium
11-50 Employees
2015
View
Visiotech Benelux
Netherlands
251-500 Employees
2007
View
Vision Engineering
United Kingdom
251-500 Employees
1958
View
Topics which have been searched by others and may be interesting for you: